|
Originally published In Press as doi:10.1074/jbc.M003884200 on July 20, 2000
J. Biol. Chem., Vol. 275, Issue 40, 31183-31190, October 6, 2000
Inter- and Intrasubunit Interactions during the Formation of
RNA Polymerase Assembly Intermediate*
Tatyana
Naryshkina ,
Dragana
Rogulja §¶,
Larisa
Golub§, and
Konstantin
Severinov **
From the Waksman Institute for Microbiology and the
Department of Genetics, Rutgers, State University of New Jersey,
Piscataway, New Jersey 08854
Received for publication, May 8, 2000, and in revised form, July 8, 2000
 |
ABSTRACT |
We used yeast two-hybrid and in vitro
co-immobilization assays to study the interaction between the
Escherichia coli RNA polymerase (RNAP) and subunits
during the formation of 2 , a physiological RNAP
assembly intermediate. We show that a 430-amino acid-long fragment
containing conserved segments F, G, H, and a short part of segment
I forms a minimal domain capable of specific interaction with . The
-interacting domain is held together by protein-protein interactions
between segments F and I. Residues in catalytically important segments H and I directly participate in binding; substitutions of
strictly conserved segment H Asp1084 and segment I
Gly1215 abolish 2 formation in
vitro and are lethal in vivo. The importance of these
amino acids in binding is fully supported by the structural
model of the Thermus aquaticus RNAP core enzyme. We also
demonstrate that determinants of RNAP assembly are conserved, and that
a homologue of Asp1084 in A135, the -like subunit of
yeast RNAP I, is responsible for interaction with AC40, the largest
-like subunit. However, the A135-AC40 interaction is weak compared
with the E. coli - interaction, and A135
mutation that abolishes the interaction is phenotypically silent. The
results suggest that in eukaryotes additional RNAP subunits orchestrate
the enzyme assembly by stabilizing weak, but specific interactions of
core subunits.
 |
INTRODUCTION |
Cellular RNA polymerases
(RNAPs)1 are large,
multisubunit enzymes. A typical prokaryotic RNAP core contains 5 polypeptides with a total molecular mass of ~400 kDa. Core RNAP from
eukaryotes and archaea contain 10-14 subunits with a total molecular
mass in excess of 500 kDa. Sequence alignments of RNAP subunits reveal extensive similarities; each of the two largest RNAP subunits, which
are the most evolutionarily conserved, contains 8-9 colinear segments
with many invariant amino acids (1, 2). RNAPs from different sources
are also homologous structurally; low resolution (16-35 Å)
three-dimensional models of Escherichia coli, and RNAP II
and RNAP I from yeast obtained by means of electron crystallography reveal significant similarities (3-5).
Evolutionarily conserved subunit segments probably form distinct
functional domains common to all RNAPs. Genetic data support this
notion; mutational changes of conserved residues selectively destroy
distinct partial functions of the enzyme (e.g. the
transition from abortive initiation to productive elongation (Ref. 6), or phosphodiester bond synthesis (Ref. 7)), but leave other functions
unperturbed. However, isolated subunits themselves do not possess any
of the partial functions of the whole enzyme (8). Therefore, RNAP
functional sites are either formed allosterically upon the enzyme
assembly, or are located at subunit interfaces. Thus, understanding
inter- and intrasubunit interactions should provide insights in RNAP
mechanism and regulation.
E. coli RNAP assembles in vivo and in
vitro according to the following scheme:
- 2- 2 - 2 ' (9).
The 2 assembly intermediate appears to be
evolutionary conserved, and an 2 -like RNAP II subassembly was isolated from yeasts (10, 11). Further, mutations in
E. coli , and in its yeast RNAP II counterpart, Rpb3,
that affect the 2 formation in their respective
systems occur in homologous positions (12, 13).
The and ' homologues are naturally fragmented in some archaea
and cyanobacteria (14, 15). The assembly pathway should be more complex
in organisms with split , ' homologues, but this has not been
investigated. Our own work with E. coli defined four
separable domains in and three in ' (16, 17), that correspond to
natural fragmentation sites in some of the archaea and cyanobacteria.
The ability to generate functional E. coli RNAP using
subunit domains greatly aided the study of RNAP assembly and
biochemical functions of assembly intermediates. A combination of
fragmented RNAP reconstitution, limited proteolysis, and
protein-protein co-immobilization assays was used to demonstrate that
determinants of specific binding reside in the C-terminal
assembly-competent structural module of , containing amino acids
907-1342 (conserved segments H and I; Ref. 18). However, similar
analysis performed by the Ishihama group (19) suggested that the
primary determinants of binding include conserved segments F and G,
corresponding to E. coli amino acids 800-900.
The discrepancy between the two sets of data illustrates problems
associated with in vitro coimmobilization assays, which can
be artifact-prone. Thus, alternative approaches are needed to
characterize the - interaction in molecular detail. Here, we used
the method of yeast two-hybrid analysis to analyze the interaction of
the and subunits during 2 formation. Our results support the conclusion of Wang et al. (18) and
directly implicate two strictly conserved amino acids in segments H
and I in interactions with .
 |
MATERIALS AND METHODS |
Proteins and Plasmids--
Gal4-based two-hybrid plasmids pPC97
(bait plasmid) and pPC86 (prey plasmid) were described in Ref. 20.
Derivatives--
The two-hybrid plasmids expressing NTD
(rpoA codons 1-235) were constructed by PCR cloning using
E. coli expression plasmids containing either wild-type
rpoA or rpoA harboring the R45A mutation as
templates (18). E. coli plasmid expressing
His6- NTD, and conditions for protein expression and
purification are described in Ref. 21.
Derivatives--
The two-hybrid plasmids expressing various
fragments of used in this work were constructed by PCR cloning
using E. coli pMKSe2 expression plasmid (22) as a template.
Site-specific PCR mutagenesis and standard recloning steps were used to
introduce point mutations in yeast two-hybrid of E. coli
expression plasmids. Full-length and ' used in in
vitro RNAP assembly studies were obtained from expression plasmids
pMKSe2 and pT7 ' (23), respectively. Overexpression was induced with
1 mM isopropyl- -D-thiogalactoside at
30 °C for 3 h. The proteins in inclusion bodies were then
prepared according to Ref. 21.
Yeast RNAP Subunit Derivatives--
The two-hybrid plasmids
expressing various fragments of yeast RNAP subunits were constructed
using appropriate primers by high fidelity PCR with yeast genomic DNA
as a template. Plasmid pNOY302, which harbors the entire
A135 gene, was provided by M. Nomura and is described in
Ref. 24.
Yeast Strains and Techniques--
Yeast were transformed using
standard lithium acetate procedure, and transformants were selected on
appropriate drop-out media. For two-hybrid assay, we used the LNY 327 tester strain provided by L. Neigeborn. This strain is identical to the
PCY2 strain of Chevrai and Nathans (20). The interaction between
two-hybrid constructs was scored using filter assays, or quantitative
colorimetric assay using ortho-nitrophenyl- -galactoside
as a substrate (25). The following formula was used to calculate
-galactosidase production: -galactosidase activity (Miller
units) = 10,000 × (OD420 1.75 × OD550)/(OD600 × t), where
OD420, OD550, and OD660 are optical density of the reaction at 420, 550, and 600 nm, respectively at time
t (min) of the reaction.
Yeast tester strain NOY302-1a was provided by M. Nomura and has been
described previously (26).
Reconstitution of 2 Complexes and
RNAP--
Purified His6 NTD was mixed with or its
derivatives (from washed inclusion bodies) at a molar ratio of 1:1 and
a total protein concentration of not more than 0.5 mg/ml in
reconstitution buffer (40 mM Tris-HCl, pH 7.9, 100 mM NaCl, 10 mM EDTA, 20 mM MgCl2, 10 µM ZnCl2, 20% (v/v)
glycerol, 2 mM -mercaptoethanol, 6 M
guanidine HCl) and dialyzed overnight at 4 °C against 2 × 2 liters of the same buffer without guanidine HCl. For RNAP
reconstitution, proteins were combined at a molar ratio : : ' of
1:1:2. At these conditions, unassembled ' precipitated during
dialysis and was removed by low speed centifugation.
Ni2+-NTA-Agarose Co-immobilization Binding
Assays--
Protein complexes (about 10 µg) were mixed with
pre-equilibrated Ni2+-NTA-agarose beads (Qiagen) in 50 µl
of reconstitution buffer and incubated for 10 min at room temperature
with gentle mixing. The beads were pelleted by centrifugation and
washed twice with 500 µl of buffer with 10 mM imidazole.
The protein samples were then eluted from the beads with buffer
containing 100 mM imidazole and analyzed by SDS-PAGE.
In Vitro Transcription--
10 µl of RNAP reconstitution
reaction was incubated for 15 min at 37 °C in the presence of 1 µg
of recombinant 70 subunit (23), and 50 ng of the T7A1
promoter-containing DNA fragment (22), 0.5 mM CpA, with or
without 25 µg/ml rifampicin. Reactions were initiated by the addition
of NTP (final concentration 25 µM ATP, CTP, and GTP, 1 µM [ -32P]UTP (1000 Ci/mmol). Reactions
proceeded for 15 min at 37 °C, and were terminated by the addition
of urea containing loading buffer. Reaction products were resolved by
denaturing 20% PAGE and revealed by autoradiography.
 |
RESULTS |
The Interaction between E. coli RNAP and Can Be Detected in
Yeast Two-hybrid System--
For our research, it was critical to
establish that the interaction between and the dimeric subunit
could be studied by two-hybrid approach, and that mutations that
decrease this strong interaction can be detected in yeast. As an
initial test, we used the N-terminal domain of (NTD, amino acids
1-235) and the subunit fragment containing amino acids 711-1246,
which specifically interact with each other in vitro (18).
-NTD was fused to the GAL4 DNA binding domain (Gal4-DB) of the bait
plasmid pPC97, and 711-1246 was fused to the GAL4
activation domain (Gal4-AD) of the prey plasmid pPC86 (20). High levels
of -galactosidase were observed when both plasmids were present
(intense blue color developed in less than 30 min in a standard filter
assay; 440 Miller units of -galactosidase activity in a quantitative
liquid assay, see "Materials and Methods"); no activity was
observed when either fusion plasmid was used separately, as expected
(cells remained white after overnight incubation on a filter, less than 1 Miller unit of -galactosidase activity). Importantly, when pPC97 1-235, carrying a mutation that changes Arg45 for Ala and weakens the interaction with (12),
was used, no activity was detected even in the presence of
pPC86 711-1246 (white color, less than 1 Miller unit of
-galactosidase activity, data not shown). Thus, we can detect the
- interaction and amino acid changes that affect this interaction
using the two-hybrid system. This result sets the stage for more
detailed analyses of RNAP assembly described below.
Defining the Minimal Fragment of Capable of Interaction with
--
Our starting two-hybrid construct,
pPC86 711-1246, contained 535 rpoB codons and
corresponded exactly to the smallest fragment that specifically
interacted with in vitro (18). The
711-1246 fragment spans four universally conserved segments, F, G, H, and part of I. To determine the smallest fragment capable of interacting with , we engineered
pPC86 711-1246 derivatives with deletions at either the
beginning or the end of the moiety, and tested these new plasmids
for their ability to elicit -galactosidase production in yeast cells
harboring pPC97 1-235. The results are schematically
presented in Fig. 1.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Determining the minimal fragment capable of interacting with in
the two-hybrid screen. The horizontal
structure at the top represents the primary
sequence of . Evolutionarily conserved regions are shaded
gray and labeled E-I according to Ref. 2. The
open boxes represent regions containing large
deletions found in homologues from Gram-positive bacteria and
chloroplasts. Dispensable regions are represented as bars
above the primary structure. The locations of Lys1065 and
His1237, which cross-link to initiating nucleotide analogs
(27), are indicated ( ). Below the primary
structure are the results of mapping the N and C termini of
Gal4-DB- NTD-interacting Gal4-AD- fragments using two-hybrid
assay, starting with the 711-1246 fragment
characterized by Wang et al. (Ref. 18). The results of the
standard -galactosidase plate assay are presented as either "+"
or " "; the numerical values to the right represent the
results of liquid -galactosidase assay in Miller units. All fragment hybrids generated less than 1 Miller unit -galactosidase
activity when combined with control R45A-Gal4-DB hybrid
(data not shown).
|
|
As can be seen, 800-1246 hybrid interacted with the hybrid. However, further deletion in segment F,
812-1246, abolished the interaction. At the C-terminal
side, removal of amino acids 1231-1246 had no effect on
interaction with . However, the removal of additional 6 amino
acids (1226-1231) abolished the interaction. The results suggest that
amino acids 711-800, which contain 80 non-conserved amino acids,
and 10 amino acids from conserved segment F, and amino acids
1231-1246, which contain most of conserved segment I, including
residue His1237, which forms the 5'-face of the catalytic
center (27), are not necessary for specific interaction with . We
note, however, that these regions of may still contribute to the
overall strength of the binding, since the two-hybrid interaction may
be saturated and insensitive to minor changes in the strength of binding.
The two-hybrid construct containing amino acids 800-1231 was the
smallest construct that interacted with strongly (520 Miller units)
and specifically (0.5 Miller units when used with R45A
two-hybrid construct) (Fig. 1). Shorter constructs, constructed by
site-directed mutagenesis, 812-1231,
832-1231, and 8oo-1225, failed to
interact with hybrid (<1 Miller unit). We also attempted to
further narrow the interacting domain by performing nested Bal31
deletion mutagenesis at either the 5' or the 3' ends of the
rpoB portion of pPC86 800-1231, transforming mutated plasmids in yeast cells harboring pPC97 , and selecting interacting (Lac+) colonies. The DNA sequence of several
interacting plasmids was determined, and in all cases Bal31
deletions extended into the vector part of
pPC86 800-1231, while rpoB codons 800 and
1231 were retained (data not shown). We conclude that
800-1231 is the minimal fragment capable of binding.
The minimal interacting fragment of , 800-1231,
contains dispensable region II ( amino acids 907-1050) that is
missing in some bacterial subunits and in homologues from
eukaryotes and archaea (28). This region tolerates an artificial split at around position 950 (16), and is highly susceptible to trypsin attack at position 907 and 911 (28). Thus, dispensable region II likely
demarcates two structurally independent modules. Earlier studies
indicated that assembly-competent module, 950-1342, which contains conserved segment H and I, interacted with
His6- -NTD (18). However, 950-1342
binding was weak compared with the binding of the larger,
711-1342, fragment or full-sized . Moreover,
950-1342 interacted with
His6- WT and
His6- R45A in vitro with the same
(low) efficiency (18). On the other hand, Nomura et al. (19)
mapped the primary -binding site to amino acids 737-904. We
constructed pPC86-based two-hybrid plasmids with
800-911 (conserved segments F and G), and
907-1231, (conserved segments H and a small portion of
I) and tested them for their ability to interact with . Neither
pPC86 711-911 plasmid, nor pPC86 907-1231
elicited -galactosidase activity with pPC97 1-235
suggesting that segments F and G, or segment H and I, alone do not
interact with in our assay (data not shown).
Our results suggest that amino acids 801-811 and 1226-1231 in
conserved regions F and I, respectively, contribute, either directly or
indirectly, to the interaction with the dimer. In the former
scenario, both segment F and segment I residues interact with to
result in strong binding; neither segment binds strongly enough for
the interaction to be detected by two-hybrid assay. The latter scenario
may involve an intrasubunit interaction between the two regions of ,
one containing segment F and G, and another containing segments H and
I. One can envision, then, that the interaction of the two fragments results in the formation of the structure which is fully
capable of binding. Two-hybrid constructs containing
800-911 and 907-1231 strongly interacted with each other (Fig. 2). In
contrast, construct containing 812-911 did not interact
with 907-1231. Likewise, no interaction was detected
between two-hybrid constructs containing 800-911 and
907-1225. Thus, the residues required for binding
are also required for intrasubunit interactions between two modules, consistent with the idea that segment F and I amino acids
contribute to binding indirectly.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
A strong intrasubunit interaction
between segments F and I. The structure
at the top represents assembly-competent E. coli
subunit fragment corresponding to archaeal ' subunit (17). The
Gal4-AD hybrids containing the fragments of shown at the
left were tested against the -Gal4-DB fragments shown
at the right, and the results are shown at far
right.
|
|
Point Mutations in Segment H and I Affect Binding in Vivo
and in Vitro--
In , substitution of the strictly conserved
Arg45 interferes with the binding (12). We hypothesized
that Arg45 interacts with a negatively charged, conserved
amino acid in , and that this interaction is responsible for the
2 formation. Accordingly, we inspected the E. coli fragment between amino acids 800 and 1231 to see if such
amino acids could be found. Segment G contains no conserved negatively
charged amino acids; segment F contains one such residue,
Glu813. This position was previously mutated to an Arg
(29); the resulting RNAP had a catalytic defect but had no assembly
defect, and therefore we did not study this position further. As can be
seen from the alignment presented in Fig.
3A, segment H contains 4 negatively charged amino acids, Asp1064,
Asp1084, Asp1095, and Glu1114,
which are strictly conserved and thus fulfill our criteria for potential candidates involved in binding. Residue
Asp1064 was mutated previously in the course of a
mutational study of the RNAP initiating site (30). The results of that
study revealed that harboring the D1064A mutation was
assembly-proficient, but the resulting RNAP was catalytically
defective. Based on these results, position 1064 was excluded from our
analysis. Segment I contains no conserved negatively charged amino
acids. However, there are three Gly residues, at positions 1215, 1218, and 1228, which are strictly conserved. Previously, we had demonstrated that substitutions of evolutionarily conserved glycines for aspartic residues in the ' subunit result in assembly defects (31). Therefore, in addition to the three site-specific mutations changing two aspartates and one glutamate from segment H for alanines, we also
substituted each of the three segment I glycines for aspartates. The
mutations were engineered in pPC86 800-1231 background, and their effect on binding in two hybrid system was studied. The
results are shown above the alignment on Fig. 3A. Of the six mutations tested, only two, D1084A and G1215D, completely abolished the
interaction as judged by both the filter and the liquid
-galactosidase assays. G1218D showed weak, but clearly positive,
interaction. The remaining mutations had no effect on binding.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 3.
Point mutations in segment H and I interfere with interactions with
. A, alignment of amino acid
sequences of E. coli segment H (top) and an
N-terminal portion of segment I (bottom) and homologues from
tobacco chloroplasts (Tobac.), archaeon Sulfolobus
acidocaldarius (Su. ac.), three nuclear
RNAPs from yeast (YP1, YP2, and YP3),
and African swine fever virus (ASFV). Strictly conserved
residues are indicated by bold typeface. The
positions of the 5'-nucleotide cross-link sites and of site-specific
mutations constructed in this work are indicated above the E. coli sequence. The values shown in parentheses represent the
results of liquid -galactosidase assay (in Miller units) obtained
with 800-1231-Gal4-AD hybrid carrying the site-specific
mutations and the -NTD-Gal4-DB hybrid. B, segment H and I
mutations were recloned into E. coli rpoB overproducing
plasmid harboring a dominant RifR mutation. Mutant subunits were overproduced, purified, and combined with
hexahistidine-tagged NTD at conditions favoring RNAP assembly.
Reactions were loaded onto Ni2+-NTA-agarose beads
(L) and the unbound protein removed (F). The
beads were then washed with buffer containing 25 mM
imidazole (W), and then the bound proteins were eluted with
buffer containing 100 mM imidazole (E). The
protein fractions were then analyzed by SDS-PAGE on a 10% gel.
C, experiment was performed as in B in the
presence of the recombinant ' subunit. Reactions were analyzed by
SDS-PAGE on a 10% gel (top) or a 6% gel
(bottom), to separate the and ' subunits.
D, RNAP was assembled as in C; reactions were
provided with purified 70 subunit, and the T7 A1
promoter-containing DNA fragment, in the presence, or in the absence of
25 µg/ml rifampicin. Transcription was initiated by the addition of
CpA primer, ATP, CTP, GTP, and [ -32P]UTP. Reaction
products were resolved by denaturing 20% PAGE and visualized by
autoradiography.
|
|
To confirm the binding defects directly, we recloned all mutations
into the pMKSe2(S531F) -overproducing plasmid (22). The subunit
expressed from pMKSe2(S531F) contains a rifampicin (Rif) resistance
mutation changing Ser531 to Phe. Therefore, Rif-sensitive
host cells transformed with pMKSe2(S531F) grow on medium containing
Rif. In contrast, cells transformed with pMKSe2(S531F) harboring the
engineered segment H and I mutations did not form colonies in the
presence of Rif, but were unaffected for growth in its absence. Thus,
the rpoB mutations behaved as recessive lethals, a phenotype
expected of assembly mutations.
The binding defect of mutants was also showed directly, by studying
their ability to co-immobilize on Ni2+-NTA-agarose through
protein-protein interactions with hexahistidine-tagged NTD (Fig.
3B). In this experiment, the wild-type or mutant subunits were prepared from inclusion bodies and combined with recombinant NTD in the presence of high concentration of denaturing agent guanidine HCl. The denaturant was dialyzed away at conditions favoring RNAP assembly, and reactions were allowed to bind to Ni2+-NTA-agarose beads. The beads were washed, and the
bound protein was eluted with a buffer containing high concentration of
imidazole. As can be seen, the wild-type was efficiently
immobilized on the sorbent in the presence of tagged NTD (Fig.
3B, lane 4), as expected. In contrast,
most of harboring the D1084A and G1215D substitutions was found in
the flow-through (lanes 6 and 10) and did not associate with NTD (lanes 8 and
12). G1218D also caused a defect in NTD binding, but, in
agreement with the two-hybrid results, the extent of this defect was
weaker than those of either D1084A or G1215D (compare lane
20 with lanes 8 and 12).
Similar analysis revealed that in agreement with the two-hybrid result substitutions at positions 1095, 1114, and 1228 had no effect in the
co-immobilization assay (Fig. 3B, lane
24; and data not shown). We conclude that positions
1084, 1215, and, to a lesser degree, 1218 are involved in binding,
and that the lethal in vivo phenotypes exhibited by the
rpoB genes harboring substitutions in these positions are
likely explained by the defect in the 2 formation. In
contrast, the lethal phenotype caused by substitutions at
rpoB positions 1095, 1114, and 1228 must be due to
alterations of some other essential RNAP function(s).
In principle, two classes of mutations can abolish protein-protein
interaction. The mutations of the first class distort the native
structure, perhaps through an allosteric mechanism, and thus prevent
the interaction. The second, most interesting class, is true
interaction mutations, which affect favorable interactions that bring
the two proteins together. We investigated the ability of the subunit harboring the D1084A and G1215D mutations to assemble into
active RNAP in vitro in the presence of the wild-type '
and hexahistidine-tagged NTD. The assembly reactions were examined
by Ni2+-NTA coimmobilization (Fig. 3C). The
addition of ' corrected the NTD-binding defect caused by the
D1084A mutation, and RNAP core enzyme was formed in good yield (Fig.
3C, lane 8). A steady-state in
vitro transcription experiment revealed transcription activity in
the RNAP assembly reactions containing with D1084A substitution (Fig. 3D, lane 3). This transcription
was rifampicin-resistant (lane 4), proving that
the activity was due to the mutant RNAP, which also carries the S531F
Rif resistance mutation, and not due to contaminating wild-type RNAP
from the host, which is rifampicin-sensitive (see lanes
5 and 6). This result implies that the D1084A
mutation does not grossly distort structure and may be directly
involved in interactions with . In contrast, no assembled RNAP was
detected in the in vitro RNAP assembly reaction containing
His-tagged , ', and carrying the G1215D mutation (Fig.
3C, lane 12), and there was no
transcription activity in G1215D assembly reactions (Fig.
3D, lanes 7 and 8). Thus,
Gly1215 appears to play a structural role, and its
involvement in binding may be indirect.
Evolutionary Conservation of the - and -like RNAP Subunit
Interactions--
In yeast, two -like subunits, AC40 and AC19, form
a heterodimer that is functionally equivalent to the 2
homodimer in prokaryotes (32). Interestingly, AC40 and AC19 are shared
by RNAP I and RNAP III. Thus, interaction of the RNAP I -like
subunit, A135, and its RNAP III homolog, C128, with the AC40/AC19
heterodimer could determine the relative amount of RNAP I and RNAP III
in the cell. We wanted to know (i) whether C-terminal A135
and C128 fragments contained determinants for interaction with the
-like subunits, as would be expected from our E. coli
results, and (ii) whether C128 and A135 interact with the
same -like subunit in the heterodimer. Two-hybrid plasmids
expressing the N- and C-terminal halves of A135 and C128 as defined by
the archaeal split were constructed. The two-hybrid plasmids were then
tested for their ability to elicit -galactosidase production with
complementary plasmids expressing either AC19 or AC40 hybrids. As
control, we used the AC40 and AC19 pair, which had previously been
shown to interact in two-hybrid assay. The results can be summarized as follows. First, as expected, AC40 fused to Gal4-DB showed strong positive interaction with AC19-Gal4-AD (120 Miller units). Second, the
N-terminal fragments of the -like subunits, containing conserved segments A, B, C, D, and E (residues 1-728 and 1-717 in C128 and A135, respectively) did not interact with the -like subunits. Third,
C-terminal fragment of C128 (residues 729-1149 conserved segments F,
G, H, and I) also did not interact with either AC19 or AC40 hybrids,
and thus no conclusions about the formation of RNAP III
2 -like structure could be made. Finally, weak (13 Miller units) interaction between the C-terminal fragment of A135
(residues 717-1203) with the AC19 hybrid, but not with the AC40 hybrid
was detected.
Since the -like subunits AC19 and AC40 heterdimerize with high
efficiency (32, see also above), the observed interaction between the
A135FGHI and AC19 two-hybrid constructs is likely due to
A135FGHI-Gal4DB interaction with AC40/AC19-Gal-AD
heterodimer. We constructed an AC19 two-hybrid plasmid, which contained
a double-alanine substitution at AC19 positions 78, and 79, corresponding to E. coli positions 44 and 45, and should
have abolished A135 binding to AC19. The resulting construct was
unaffected in A135FGHI interaction (15 Miller units),
suggesting that conserved residues in the -motif of AC19 are not
involved in A135 binding, or A135 interacts with AC40. To establish the
specificity of two-hybrid interaction between AC40/AC19-Gal-AD and
A135FGHI-Gal4DB, we engineered a two-hybrid construct that
expressed the C-terminal fragment of A135 with D935A substitution,
which corresponds to E. coli rpoBD1084A (Fig.
3A). No -galactosidase was produced when the AC19 and A135D935A hybrids were combined in the same yeast cell (1 Miller unit). We conclude that (i) the C-terminal portion of
A135 interacts with the largest -like subunit, AC40, and not with
AC19, and (ii) A135 Asp935 is required for this interaction.
In E. coli, rpoB mutations that abolish the
strong - interaction behave as haploinviable (see above). To test
the functional consequence of D935A substitution in A135,
which abolishes the A135-AC19/AC40 interaction in the two hybrid assay,
yeast plasmid expressing the mutant A135 gene was
constructed. The phenotype of this gene was tested using haploid
NOY408-1a yeast tester strain (26). In this strain the chromosomal
copy of A135 has been deleted, and the cells are kept viable
because of the presence of a multicopy plasmid harboring an rDNA repeat
under the control of GAL7 (RNAP II) promoter. Therefore,
NOY408-1a is only viable when galactose is present and does not grow
in the presence of glucose, when the GAL7 promoter is
repressed. However, when a plasmid expressing a functional copy of
A135 is introduced, NOY408-1a can grow in the presence of
glucose, since rDNA is now transcribed by RNAP I. As can be seen,
plasmid-borne A135D935A, allowed robust growth
on glucose (Fig. 4). Additional
experiments established that the A135D935A
plasmid allowed growth on glucose at low temperature of 16 °C, and
at high temperature of 37 °C (data not shown). We conclude that the
A135D935A gene is functional.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Yeast A135 harboring
mutation that abolishes A135 interaction with AC40/AC19 in two-hybrid
system is functional. Yeast tester strain NOY308-1a, which lacks
A135 and is kept viable by the presence of
Gal7-rDNA plasmid (26), was transformed with vector plasmid
or plasmids expressing wild-type A135, or mutant
A135 with D935A substitution. Transformants were spotted on
rich medium containing galactose (top row) or
glucose (bottom row) as carbon source. The
results of growth after a 62-h incubation at 30 °C are
presented.
|
|
 |
DISCUSSION |
The impetus for this study came from the apparently contradictory
results of Nomura et al. (19) and Wang et al.
(18), who localized the -binding determinants into non-overlapping fragments of E. coli . Nomura et al. claimed
that conserved segments F and G, harbor the primary -binding
site; Wang et al. localized the binding site to segments
H and I; however, four conserved regions, F, G, H, and I, were required
for strong and specific binding. The results of our work are
consistent with Wang et al., and demonstrate that amino
acids 1084 (conserved segment H) and 1215 (conserved segment I) are
involved in binding. We also demonstrate that there exists a strong
intrasubunit interaction between segments F and I, and that this
interaction appears to be necessary for binding. Finally, we
present evidence that, in yeast, the second largest, -like RNAP I
subunit A135 interacts with the larger -like subunit, AC40, and,
unexpectedly, that the A135 mutation that abolishes this interaction is
viable. While this research was in progress, a 3.3-Å structure of RNAP
core from Thermus aquaticus (Taq) appeared (33).
In addition, a medium resolution structure of yeast RNAP II also became
available (34). Below, we interpret our findings in the context of the
structural model of the Taq enzyme.
Intrasubunit Interaction of between Segment F and I Residues Is
Important for Binding--
Our results demonstrate that the
smallest fragment of E. coli capable of specific binding spans amino acids 800-1231. The structural context of the
corresponding fragment of Taq is shown in Fig.
5 (A-C). As can be seen, the
fragment has an elongated shape and consists of two domains. One domain
is formed entirely by conserved segment G and contains the so-called
"flexible flap" element, which is thought to interact with RNA at
hairpin-induced pause sites (35), and harbors the site of trypsin
attack (28). The second domain contains the entire conserved segment H
as well as segments FC and IN, which are far
away from each other in the primary sequence. The second domain is
involved in protein-protein interactions with one monomer, 1.
The second monomer, 2, does not interact with and instead
contacts '.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 5.
Structural context of the minimal
domain capable of binding and assembly mutations.
The RIBBONS diagram of the three-dimensional structure of
Taq RNAP core enzyme is shown (33). The subunit is
indicated in blue, ' in magenta, 1 in
green, 2 in yellow, and in
white. The active center Mg2+ is shown in
red and spacefill. The domain of corresponding to E. coli resides 800-1231 is shown in
cyan. A, view roughly parallel with the main axis
of the RNAP channel. The active site Mg2+ is seen through
the secondary channel. B, view A rotated 90°
clockwise about the vertical axis. C,
view A rotated 180° about the vertical axis, giving a view
down the opposite end of the main channel. D, the RIBBONS
diagram of Taq fragment corresponding to E. coli -binding domain 800-1231(cyan) complexed with
1 (green). The catalytic Mg2+ is shown in
spacefill and red. Parts of segments F and I
important for intrasubunit interaction are shown in magenta
and orange. The 1 residue corresponding to E. coli Arg45 is shown in yellow and
spacefill. E, the view in D was
rotated approximately 90o counterclockwise about the
horizontal axis. Taq residues corresponding to E. coli residues corresponding to E. coli positions that
when mutated alter binding, as well the catalytic residues involved
in substrate interactions are indicated, and shown in color
and spacefill. Residues indicated in white
correspond to E. coli residues 1095, 1114, and 1228, and
are not involved in binding.
|
|
The -binding domain is held together by a 6-strand antiparallel
-sheet. Conserved segments F, H, and I contribute to this sheet,
and stretches of amino acids corresponding to E. coli 800-812 and 1226-1231 each form interacting strands (Fig.
5D). We registered this intrasubunit interaction as a strong
-galactosidase production when hybrids containing E. coli
800-907 and 911-1231 were combined.
Removing either segment F or segment I amino acids disrupts the
structure of the entire -binding domain, and as a consequence
abolishes binding.
Segment H and I Amino Acids Participate in Binding--
The
prototypical E. coli mutation that decreases the avidity of
binding to changes Arg45 which is evolutionary
conserved (12). We hypothesized that, in , the likely counterpart of
Arg45 is negatively charged and evolutionarily
conserved. Out of three possible candidates, all of which were located
in segment H, only one, Asp1084, when mutated affected binding both in two-hybrid assay, and in in vitro
co-immobilization experiments. In addition, substitution of segment I
Gly1215 also abolished binding.
The structure reveals that Taq Asp857, which is
homologous to E. coli Asp1084, is indeed in
direct contact with Arg42 (E. coli
Arg45) in 1 (Fig. 5E). Taq
Gly977, which is homologous to E. coli Gly1215, is located at the tip of a loop formed by segment
I and buttresses Asp857 (E. coli
Asp1084) to position it such that it can correctly interact
with Arg42 of 1. The G1215D substitution that we
engineered probably causes unfavorable electrostatic interaction with
Asp1084 and may significantly alter the conformation of the
-binding domain. In agreement with this idea, G1215D abolished the
' entry in the complex. In contrast, RNAP harboring D1084A
mutation assembled efficiently and was active. Thus, ' can stabilize
the 2 subassembly, presumably through independent
protein-protein interactions with the second monomer, 2, and
. Of the remaining four mutations that we engineered, one (G1218D)
substantially decreased binding, while others had no effect.
Taq Gly980 (E. coli
Gly1218) is in the same loop as Taq
Gly977 (E. coli Gly1215); it
makes no contacts with and is at least 10 Å away from Arg42 (E. coli Arg45). Thus, G1218D
substitution inhibits -binding indirectly, probably by affecting the
relative position of the stabilizing Gly1215. The
importance of precise positioning of Arg45 and Asp1084 for 2 formation is underscored by
the fact that no interaction was detected when a pair of mutants
containing an Asp in place of Arg45 and an Arg instead of
Asp1084 was tested (data not shown).
The -binding domain of also contains two strictly conserved
residues that are implicated in catalysis, and that are exposed into
the DNA-binding channel of the enzyme, close to the catalytic Mg ion.
In segment H, Taq Lys838 (Lys1065 in
E. coli) contacts the -phosphate of the initiating purine nucleotide (6); in segment F Taq Glu685
(Gly813 in E. coli) is probably required for
proper interaction with incoming NTP (29). Binding of thus
stabilizes the active center conformation. In agreement with this idea,
we had found that in the absence of ', is necessary to induce
specific binding of initiating purine nucleotide by the subunit.2
Yeast RNAP Assembly--
Our studies of yeast RNAP subunit
interactions reveal several important points. First, as expected, the
determinants of binding reside in the C-terminal portion of A135,
the -like subunit of RNAP I, and Asp935, which is
homologous to E. coli Asp1084 is required
for this interaction. This result is in agreement with recent RNAP
interaction mapping by Flores et al. (36). These authors
reported that A135 segment 678-1055, containing conserved segments E,
F, G, H, and IC (corresponding to E. coli positions 642-1253), bound both AC19 and AC40 in two-hybrid assay. Our
interacting fragment of A135 contained conserved segments F, G, H, and
entire I (amino acids 716-1201), and corresponded to E. coli residues 681-1342. Based on mutational analysis, A135
appears to interact with the larger -like subunit, AC40, and not
with the smaller AC19. This is consistent with structural analysis of
yeast RNAP II by the Kornberg group (34), who observed that the largest
-like subunit, Rpb3, contacts the -like Rpb2. Our data indicate
that, in yeast, the interaction between the -like and the -like
subunits of RNAP I is much weaker than the corresponding interaction in
E. coli, and A135 mutations that abolish this
interaction are viable. The corresponding interaction may be even
weaker in case of RNAP III. We and others (36) were unable to detect
any interaction between RNAP III -like subunit C128 and AC40/AC19
using two-hybrid assay. Additional RNAP subunits may strengthen the
weak 2 -like complex in eukaryotes. Indeed, the
AC40/AC19 heterodimer was shown to bind ABC10 (Rpb10) shared RNAP
subunit (32). More recently, crystallographic analysis revealed that
ABC10 and ABC10 (Rpb12) bind to the larger -like subunit Rpb3
in yeast RNAP II and anchor it on the -like Rpb2 (34). An
alternative possibility would be that the eukaryotic 2 -like complex is stabilized by the entry of the
largest, '-like subunit in the complex, similar to the situation
observed with E. coli D1084A mutation. This latter
scenario envisions that the relative amount of RNAP I and III in the
cell is chiefly determined by the joint availability of catalytic and '-like subunits, which are specific, and not by the shared
-like subunits.
 |
ACKNOWLEDGEMENT |
We thank Lenore Neigeborn (Rutgers University,
Piscataway, NJ) for two-hybrid plasmids and advice.
 |
FOOTNOTES |
*
This work was supported in part by a Burroughs Wellcome Fund
for Biomedical Research career award, by National Institutes of Health
Grant RO1 59295, and by March of Dimes Birth Defects Foundation
Research Grant FY99-479 (to K. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
Supported by Waksman undergraduate fellowships.
¶
A Henry Rutgers Scholar. Supported by a New Jersey Commission
for Cancer Research summer fellowship.
**
To whom correspondence should be addressed: Waksman Inst., 190 Frelinghuysen Rd., Piscataway, NJ 08854. Tel.: 732-445-6095; Fax:
732-445-5735; E-mail: severik@waksman.rutgers.edu.
Published, JBC Papers in Press, July 20, 2000, DOI 10.1074/jbc.M003884200
2
T. Naryshkina, A. Mustaev, S. Darst, and K. Severinov, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
RNAP, RNA
polymerase;
PCR, polymerase chain reaction;
PAGE, polyacrylamide gel
electrophoresis;
NTA, nitrilotriacetic acid;
Rif, rifampicin;
NTD, N-terminal domain;
Gal4-DB, GAL4 DNA binding domain;
Gal4-AD, GAL4
activation domain.
 |
REFERENCES |
| 1.
|
Allison, L. A.,
Moyle, M.,
Shales, M.,
and Ingles, C. J.
(1985)
Cell
42,
599-610
|
| 2.
|
Sweetser, D.,
Nonet, M.,
and Young, R. A.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1192-1196
|
| 3.
|
Polyakov, A.,
Severinova, E.,
and Darst, S. A.
(1995)
Cell
83,
365-373
|
| 4.
|
Darst, S. A.,
Edwards, A. M.,
Kubalek, E. W.,
and Kornberg, R. D.
(1991)
Cell
66,
121-128
|
| 5.
|
Schultz, P.,
Celia, H.,
Riva, M.,
Sentenac, A.,
and Oudet, P.
(1993)
EMBO J.
12,
2601-2607
|
| 6.
|
Kashlev, M.,
Lee, J.,
Zalenskaya, K.,
Nikiforov, V.,
and Goldfarb, A.
(1990)
Science
248,
1006-1009
|
| 7.
|
Zaychikov, E.,
Martin, E.,
Denissova, L.,
Kozlov, M.,
Markovtsov, V.,
Kashlev, M.,
Heumann, H.,
Nikiforov, V.,
Goldfarb, A.,
and Mustaev, A.
(1996)
Science
273,
107-109
|
| 8.
|
Zillig, W.,
Palm, P.,
and Heil, A.
(1976)
in
RNA Polymerase
(Losick, R.
, and Chamberlin, M., eds)
, pp. 101-125, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 9.
|
Ishihama, A.
(1981)
Adv. Biophys.
14,
1-35
|
| 10.
|
Kolodziej, P. A.,
and Young, R. A.
(1991)
Mol. Cell. Biol.
11,
4669-4678
|
|